BioCardia Says Submitted 510(K) For Approval Of Its Patented Morph DNA Steerable Introducer Sheath
Portfolio Pulse from Benzinga Newsdesk
BioCardia has submitted a 510(K) application for approval of its patented Morph DNA Steerable Introducer Sheath, which is designed to facilitate the introduction of medical instruments into the peripheral and coronary vasculature.
July 30, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioCardia has submitted a 510(K) application for its Morph DNA Steerable Introducer Sheath, which could enhance the introduction of medical instruments into the heart's vasculature.
The submission of a 510(K) application is a significant step towards regulatory approval, which could lead to market entry and potential revenue growth for BioCardia. This news is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100